Cardiac Surgery Market Size, Share & Trends Analysis - Global - 2024-2030 - MedSuite - Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 20 more
Product Overview
In 2023, the global cardiac surgery device market reached a value of $17.1 billion, with a projected growth rate of 5.5% to reach $24.9 billion by the end of the forecast period. Currently, key market players such as Edwards Lifesciences, Abbott, and Medtronic hold the majority of the global market share.
The comprehensive report suite covering the global cardiac surgery device market includes various segments like tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair systems, transcatheter heart valve replacement devices, cerebral embolic protection devices, balloon valvuloplasty devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion devices, endoscopic vessel harvesting devices, anastomosis assist devices, ventricular assist devices, intra-aortic balloon devices, artificial heart replacement devices, patent foramen ovale closure devices, patent ductus arteriosus closure devices, atrial and ventricular septal defect closure devices, left atrial appendage closure devices, preshaped guidewires, transmyocardial revascularization devices, and extracorporeal membrane oxygenation (ECMO) systems.
DATA TYPES INCLUDEDUnit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2030, and Historical Data to 2020
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
COVID19 ImpactDisease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Cardiac Surgery Market Insights
Inflationary pressures persist, leading to a continuous increase in prices within the global cardiac surgery device market. While the inflation rate is predicted to decrease during the forecast period, device prices are anticipated to continue their upward trend.
Concurrently, there is a noticeable trend towards minimally invasive procedures, which not only improve patient outcomes but also streamline surgical complexities. Key procedures in this shift include transcatheter aortic valve implantation (TAVI) and transcatheter mitral valve repair (TMVr).
Global Cardiac Surgery Market Share InsightsIn 2023, Edwards Lifesciences emerged as a dominant force in the global cardiac surgery device market, leading in four specific segments. Although not topping the TMVr devices segment, Edwards is poised to maintain its market leadership due to strong performances in other areas.
Securing the second position among competitors in the global cardiac surgery device market for 2023 was Abbott. Renowned for its extensive product lineup, Abbott is a formidable presence in its target markets and is poised to expand its share within the cardiac surgery sector, further solidifying its position in the global medical device industry.
Medtronic occupied the third position in the global cardiac surgery device market in 2023. With a significant presence in various segments, including tissue and mechanical heart valves, annuloplasty repairs, and transcatheter heart valves, among others, Medtronic is expected to maintain its robust market presence in the foreseeable future.
Market Segmentation Summary
Tissue Heart Valve Market – Includes:Stented tissue heart valves, stentless heart valves, and sutureless heart valves.
Mechanical Heart Valve Market
Annuloplasty Repair Device Market
Transcatheter Mitral Valve Repair (TMVr) Market
Transcatheter Heart Valve Replacement Market – Includes:Transcatheter aortic valve replacement devices, Transcatheter pulmonary valve replacement devices.
Cerebral Embolic Protection Device Market
Balloon Valvuloplasty Device Market – Includes:Aortic, Mitral, Pulmonary.
On-Pump Coronary Artery Bypass Device Market – Includes:ONCAB disposables, Perfusion systems.
Off-Pump Coronary Artery Bypass Device Market – Includes:Stabilizer devices, positioners.
Autotransfusion Device Market – Includes:Autotransfusion machines, autotransfusion disposables.
Endoscopic Vessel Harvesting Device Market
Anastomosis Assist Device Market
Ventricular Assist Device Market – Includes:Implantable VAD, percutaneous VAD.
Intra-Aortic Balloon Device Market – Includes:IAB catheters, IABP consoles.
Artificial Heart Replacement Device Market
Patent Foramen Ovale Closure Device Market
Patent Ductus Arteriosus Closure Device Market
Atrial & Ventricular Septal Defect Closure Device Market – Includes:Atrial septal defect closure devices, ventricular septal defect closure devices.
Left Atrial Appendage Closure Device Market – Includes:
Endocardial LAA devices, epicardial clip LAA devices, epicardial suture LAA devices.
Preshaped Guidewire Market
Transmyocardial Revascularization Device Market – Includes:Single-use fiber-optic handpieces, laser consoles, laser console service.
Extracorporeal Membrane Oxygenation Market – Includes:ECMO disposables, ECMO machines.
Global Research Scope Summary
Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2023
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.